Just reading between the lines of the article it is likely that an IND has been filed and no holds have been placed by the FDA - especially if Merck Sorono has formed a partnership with this biotech company. It's not in the FDA Orange book because these in-licensing agreements tend to happen during the Phase II clinical trial stage. I'll try to check on this at work, but I would imagine it will be a while before we see Phase III results.